Should Women Receive Left Ventricular Assist Device Support?
- 1 March 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 5 (2) , 234-240
Abstract
Background—: Small studies have reported women to have worse outcomes and more adverse events after implantation of mechanical circulatory support device compared with men. To further evaluate sex differences in outcome, we used the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). Methods and Results—: There were 401 women (pulsatile devices=78) and 1535 men (pulsatile devices=402) from 89 institutions who were prospectively enrolled into the INTERMACS database for primary implantation of a left ventricular assist device (LVAD) between June 23, 2006, and March 31, 2010. Extensive preimplantation and outcome data were collected on all patients. With a mean follow-up of 7 months, 67 females (17%) died and 250 males (16%) died. There was no statistically significant sex difference in mortality for either pulsatile-flow ( P =0.82) or continuous-flow ( P =0.95) devices in adjusted and unadjusted models. There were also no statistically significant sex differences with time to first infection, bleeding, or device malfunction. However, female sex was associated with an increased hazard of first neurological event (adjusted hazard ratio, 1.44; 95% CI, 1.05–1.96; P =0.020). Conclusions—: There were no significant sex differences in mortality, time to first infection, bleeding, or device malfunction with either pulsatile- or continuous-flow LVADs. However, women had an increased risk of first neurological event. For urgent/emergent mechanical support, the benefit of LVAD support likely outweighs the risk, but it remains less clear for women undergoing elective LVAD implantation.Keywords
This publication has 20 references indexed in Scilit:
- Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantationThe Journal of Heart and Lung Transplantation, 2011
- Model for End-Stage Liver Disease Score Predicts Left Ventricular Assist Device Operative Transfusion Requirements, Morbidity, and MortalityCirculation, 2010
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceNew England Journal of Medicine, 2009
- 181: Early Neurological Adverse Events (NAE) after Pulsatile VAD Implantation in 455 Patients: Incidence, Severity and OutcomeThe Journal of Heart and Lung Transplantation, 2009
- Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly SubjectsClinical Pharmacokinetics, 2008
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationNew England Journal of Medicine, 2007
- A Decade of Short-Term Outcomes in Post–Cardiac Surgery Ventricular Assist Device ImplantationCirculation, 2007
- Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseasesEuropean Heart Journal, 2005
- Gender in the Pharmacy: Does It Matter?2005
- Effect of gender on bridging to transplantation and posttransplantation survival in patients with left ventricular assist devicesThe Journal of Thoracic and Cardiovascular Surgery, 2004